Using different types of bacteria and a canine model simulating human septic shock, we investigated the role of endotoxin in cardiovascular dysfunction and mortality. Either Escherichia coli (a microorganism with endotoxin) or Staphylococcus aureus (a microorganism without endotoxin) were placed in an intraperitoneal clot in doses of viable or formalin-killed bacteria. Cardiovascular function of conscious animals was studied using simultaneous radionuclide heart scans and thermodilution cardiac outputs. Serial plasma endotoxin levels were measured. S. aureus produced a pattern of reversible cardiovascular dysfunction over 7-10 d that was concordant (P < 0.01) with that of E. coli. Although this cardiovascular pattern was not altered by formalin killing (S. aureus and E. coli), formalin-killed organisms produced a lower mortality and less myocardial depression (P < 0.01). S. aureus, compared to E. coli, produced higher postmortem concentrations of microorganisms and higher mortality (P < 0.025). E. coli produced significant endotoxemia (P < 0.01), though viable organisms (versus nonviable) resulted in higher endotoxin blood concentrations (P < 0.05). Significant endotoxemia did not occur with S. aureus. Thus, in the absence of endotoxemia, S. aureus induced the same cardiovascular abnormalities of septic shock as E. coli. These findings indicate that structurally and functionally distinct microorganisms, with or without endotoxin, can activate a common pathway resulting in similar cardiovascular injury and mortality.
Introduction
Septic shock is a highly lethal disorder that produces profound cardiovascular abnormalities in humans. Within 2-3 d of onset, patients typically have a decreased left ventricular ejection fraction with left ventricular dilation, and normal or increased cardiac output (1) (2) (3) . In survivors of septic shock, these cardiovascular changes return to normal in -7-10 d.
Gram negative bacteria and the endotoxin they produce, are closely associated with septic shock. Previous studies have shown that gram negative bacillary septicemia frequently produces shock and a high mortality. This shock state is thought by many to be so distinctive that it constitutes a specific syndrome (4-6). However, recent clinical studies and experience indicate that many microorganisms, including fungi and gram positive bacteria (microorganisms without endotoxin), can produce a pattern ofcardiovascular dysfunction similar to that of gram negative septic shock (1) (2) (3) (7) (8) (9) (10) (11) (12) (13) (14) .
Unlike septic shock caused by gram negative bacteria, septic shock caused by gram positive bacteria or fungi has not been shown to be closely linked to specific toxins or bacterial products. Peptidoglycan, a structural component of the cell wall of gram positive bacteria, can produce endotoxin-like effects; however, the biological activity of endotoxin is quantitatively greater (5 X I09) than that of peptidoglycan (15) . The cardiovascular effects of these peptidoglycans have not been previously evaluated. Although controversial, some studies suggest that microorganisms without endotoxin may cause septic shock by disrupting the mucosal barrier of the host intestines so that gram negative bacteria (or their endotoxin) leak into the bloodstream. Proponents of this theory suggest that this route is the final common pathway of irreversible shock produced from any etiology (16) (17) (18) .
In the present study, the cardiovascular changes produced by a gram negative bacteria (Escherichia coli) and a gram positive bacteria (Staphylococcus aureus) were compared in a canine model that was designed to simulate closely human septic shock (19, 20) . We examined the relationship of cardiovascular changes to microorganism viability for both types of bacteria. Plasma endotoxin was serially determined during the course of infection using a sensitive chromogenic limulus amebocyte lysate assay to study the potential role ofendotoxin in producing the severe hemodynamic abnormalities found in septic shock.
Methods
Experimental design. The general protocol used in this study has been previously described (19) . The specific protocol used in this study is diagramed in Fig. 1 . A complete hemodynamic evaluation and routine laboratory blood analysis were performed on each dog at the baseline time point, which was 1 wk before surgery. At each time point, we inserted intravascular catheters using local subcutaneous anesthesia (1% lidocaine) and obtained blood samples for laboratory analysis. Hemodynamic data were then obtained in awake nonsedated dogs simultaneously from intravascular pulmonary and femoral artery catheters and from gated radionuclide cineangiography of the left ventricle. After giving animals an intravascular volume infusion, we then repeated simultaneous hemodynamic and radionuclide studies. Intravascular catheters were removed after completing the evaluation.
Surgery was performed as previously described (19) . On day 0, we placed a fibrin clot containing I microbiological preparation in the peritoneal cavity (Table I) . 86 2-yr-old beagles, weighing a mean±SEM of 1 (21) . The E. coli strain was characterized as a nonhemolytic, nonencapsulated, serum sensitive (human and dog), colicin v negative, serotype 086;H8 (22, 23). All experiments throughout this paper were performed with these two strains ofbacteria unless otherwise stated.
Bacteria were stored in l-ml aliquots of bacto-peptone infusion broth (Difco Laboratories, Detroit, MI) and glycerol at -70'C. To prepare viable bacterial doses, we inoculated 500 ml of brain-heart infusion broth with a l-ml aliquot of thawed bacteria. Bacteria were incubated for 18 h, centrifuged, and then washed twice in sterile saline. Concentration Table I . Bacteria were added to the fibrin clot using the method previously described (19) .
Physiologic measurements and hemodynamic calculations. All hemodynamic measurements were made using techniques previously described (19) . Measurements were obtained from indwelling femoral and balloon flotation pulmonary artery catheters in nonanesthetized animals resting quietly in slings. Radionuclidegated blood pool scanning was performed using conventional techniques to determine the left ventricular ejection fraction in awake nonsedated animals ( 19) .
The hemodynamic data were indexed by animal body weight in kilograms. The following values were calculated according to the standard formulas previously described: cardiac index (CI)' (ml/kg per min), and stroke volume index (SVI) (ml/kg per beat) (19) . The end diastolic volume index (EDVI) (ml/kg) and end systolic volume index (ESVI) (ml/kg) were calculated from hemodynamic studies and radionuclide scans using the formulas EDVI = SVI (from thermodilution cardiac output)/EF (from radionuclide cineangiography) and ESVI = EDVI -SVI.
Limulus amebocyte lysate assay. Serial blood samples were obtained from all dogs at baseline, days 1, 2, and 10 postsurgery. Samples (3 ml) were placed in sterile, pyrogen-free, sodium heparinized glass tubes (2 U. S. Pharmacopeia units/ml of whole blood). Additional blood specimens were obtained from dogs infected with S. aureus at 4 and 10 h postsurgery and from nonsurviving dogs immediately after death to test for endotoxemia. The blood was continuously mixed until centrifuged at 400 g for 10 min; the plasma was transferred into pyrogen-free screw-capped glass tubes and stored at -20'C until assayed. No difference was observed between endotoxin levels ofplatelet-rich or platelet-poor plasma specimens (n = 18, P > 0. (18, 19) . units per ml (1 EU/mil = 0.1 mg each ofU. S. standard endotoxin) were determined from a standard curve based on known amounts of purified endotoxin assayed in H20.
The reactions were carried out on plastic microtiter tissue culture plates (Costar, Cambridge, MA) and measured with a microtiter plate reader (Titertek, Multiskan MC; Flow Laboratories, McLean, VA).
Quantitative blood and tissue cultures. Quantitative blood and tissue cultures were done for each group of dogs to compare generation times and intrinsic invasive properties of these viable strains of S. aureus and E. coli. Six 2-yr-old beagles (mean±SE weight 12.5±0.8 kg) had a clot with 7 X I09 per kg body wt organisms implanted intraperitoneally. Three dogs received E. coli and three dogs received S. aureus. Quantitative blood cultures were obtained from dogs before surgery, 2 h after surgery, and then every 8 h for 24 h. From previous experiments, we knew that S. aureus was more rapidly lethal than E. coli. To obtain liver, lung, and spleen tissue for quantitative tissue cultures and to perform quantitative organ cultures at the same time for dogs receiving S. aureus and dogs receiving E. coli, we decided to kill a dog receiving E. coli whenever a dog receiving S. aureus died. Consequently, we then had tissue cultures obtained at comparable time points for dogs challenged with S. aureus and dogs challenged with E. coli. All dogs surviving 24 h were killed with T-61 Euthanasia Solution (Taylor Pharmacal Co., Decatur, IL).
Quantitative blood culture concentrations were measured in petri dishes by plating successive 10-fold dilutions of 1 ml of blood in pour tubes and then scoring by counting visible colonies after 24 h incubation at 370C. The quantitative tissue culture concentrations were obtained by homogenizing I g oftissue with 3 ml oftryptic soy broth and then doing successive dilutions with pour tubes as above.
Experiments with another E. coli strain. Since E. coli strain 086;H8 is not a common human pathogen, and is not encapsulated, hemolytic, and serum resistant, virulence factors commonly associated with human infections (22, 23), we repeated a number of experiments with E. coli strain 06;HI;K2. This E. coli, which is frequently found in extraintestinal human disease, was provided by the Statens Serum Institut (Copenhagen, Denmark). This organism is encapsulated, hemolytic, and serum-resistant (22, 23) .
In these additional experiments, 14 (26) . A coefficient of concordance value of 1 indicates complete agreement among the assigned ranks, and a value of0 indicates maximal disagreement. The shaded areas in Figs. 2 and 3 represent the normal ranges based on data from 100 control dogs, the width of the range being adjusted to the size of the experimental group.
Relative frequencies ofdeath were compared using the Fisher exact test. The doses of viable and nonviable S. aureus, for which relative frequency of death was compared, were not equal. Nevertheless, the highest dose of viable organism administered (7 X I09) was associated with 100% lethality. This dose was less than one-fourth the dose of nonviable organisms (30 X 109), which caused no deaths.
Endotoxin levels were adjusted to baseline time points (Table III) (27) . Median endotoxin levels on days 1 and 2 were compared using a Mann-Whitney test (26) Figure 3 . The format is the same as Fig. 2 s is based on data from all groups (Table I) Table III ). Dogs receiving viable E. coli when compared to dogs receiving nonviable E. coli had greater endotoxemia (P < 0.05). By day 10, endotoxin levels of dogs from all four groups were not significantly different from endotoxin levels at baseline. Dogs receiving viable S. aureus (1 X 109) had additional endotoxin levels measured at 4 and 10 h postsurgery and had no significant endotoxemia. Furthermore, dogs in the group receiving lethal doses of S. aureus (7 X 109) had endotoxin levels measured at 4 and 10 h postsurgery, and immediately postmortem, and had no significant endotoxemia. Quantitative blood and tissue cultures. Dogs infected with S. aureus to obtain quantitative cultures died ofseptic shock at a mean (±SE) of 15.6±0.7 h post-clot implantation. Since the E. coli dose of 7 X 109 per kg body wt was nonlethal within 24 h after clot implantation, the dogs given this dose were each sacrificed at the time ofdeath of one ofthe dogs treated with S. aureus. Quantitative blood cultures were not significantly different between the dogs infected with this S. aureus and E. coli at 0, 2, and 8 h post-clot implantation (Table IV) . However, comparison of tissues revealed that postmortem liver, lung, and spleen concentrations of bacteria were greater (P < 0.025) in dogs infected with S. aureus than in dogs infected with E. coli.
Experiment with another E. coli strain. To address the question regarding the behavior of an E. coli organism with more virulence characteristics in this animal model, we performed further studies on 11 dogs who were infected with an E. coli that manifested more virulence factors associated with human infection (22, 23). An additional four dogs were in- CFU/kg body wt dose produced 100% mortality. P < 0.01. fected with another E. coli strain serotype 06;H1 ;K2 at a dose of 1 X I09 viable colony forming units per kg body wt. Hemodynamic testing of these dogs was the same as that used for all the dogs described earlier (see Results). Hemodynamic data collected on each of 4 d (baseline, days 1, 2, 10 postsurgery) were reduced to ranks that were compared to the corresponding mean ranks representing averages of hemodynamic data over the original six groups of dogs (see Methods). Such comparisons were made for the following hemodynamic variables: PCWP, MAP, CI, SVI, EF, EDVI, and ESVI. No significant difference was found in the respective paired sets of ranks (levels of significance ranged from 0.08 to 0.99 with an overall level of 0.54). Therefore, we concluded that the findings obtained with this strain of E. coli tended to be concordant with the results observed earlier. Six additional dogs were studied, using the quantitative blood and tissue culture methods previously described (see Results). Three dogs were infected with E. coli (serotype strain 06;HI;K2) and, for comparison, three dogs were infected with the S. aureus (capsular serotype 8).
Both microorganisms were implanted in the dogs peritoneum at a dose of7 X 109 viable colony forming units per kg body wt.
Results from quantitative blood cultures were not significantly different between this strain of E. coli and S. aureus at 0, 2, and 8 h post-clot implantation (Table IV) . However, S. aureus (capsular serotype 8) per colony forming unit implanted intraperitoneally, produced greater concentrations of bacteria (P < 0.025) in postmortem tissue (liver, lung, and spleen) than that ofE. coli serotype 06;H 1 ;K2 and, as described previously, that of E. coli serotype 086;H8. Finally, an additional four dogs were infected with the virulent strain E. coli serotype 06;HI;K2 at a dose of 7 X 109 viable colony forming units per kg body wt for survival studies alone using the same procedure as'that described previously (see Results). Of these 4 dogs infected with E. coli (serotype 06;H1;K2), one animal died on day 8 post-clot implantation and the remaining 3 dogs survived. As described earlier, the S. aureus. (capsular serotype 8) at this dose (7 X 109 viable bacteria per kg body wt implanted intraperitoneally) was 100% lethal within 24 h. Thus, S. aureus (capsular serotype 8) compared to E. coli (serotype 06;H 1;K2), per colony forming unit implanted intraperitoneally was more rapidly lethal (P < 0.02), and, as stated earlier, this S. aureus was also more lethal than E. coli serotype 086; H8. Thus, compared to two E. coli strains (06; H 1;K2 and 086;H8), S. aureus (capsular sero- In previous studies (19, 20) , we implanted a viable E. coli into the peritoneum of dogs to study a canine model of septic shock with systolic and diastolic cardiovascular dysfunction similar to the hemodynamic profile observed in human septicemia. In the present study, a qualitatively indistinguishable pattern of cardiac abnormalities was also found using a viable and nonviable S. aureus and a nonviable E. coli. On day 2 postsurgery, after receiving adequate fluid resuscitation, animals had a decreased LVEF, dilated LV (increased EDVI and ESVI), and maintained or increased SVI and CI. These changes returned back toward normal (baseline) in 7-10 d. This pattern and time course is similar to that ofhuman septic shock (1) (2) (3) .
Clinical data from studies of human septic shock suggest that different types of microorganisms produce similar hemodynamic profiles (1) (2) (3) (7) (8) (9) (10) (11) (12) (13) (14) . The hemodynamic data obtained in this study using a canine model of septic shock are similar to data obtained from clinical studies on humans. Furthermore, the data suggest that during septic shock microorganisms with vastly different structural and molecular compositions can activate a common pathway leading to qualitatively similar severe cardiovascular dysfunction (1) (2) (3) (7) (8) (9) (10) (11) (12) (13) (14) . Presumably, the different microorganisms that cause septic shock induce the same endogenous mediators that then directly affect target tissues such as the myocardium, vascular endothelium and smooth muscle, and cells of the immune system. Even though a variety of bacteria produce a similar pattern of injury (1) (2) (3) , we speculate that heterogeneity in the clinical manifestation of septicemia may depend on both host resistance factors and important but incompletely defined microorganism virulence factors, such as the ability of different microorganism to overcome host defenses, multiply, and produce toxins of variable potency.
The present study confirms that microorganisms without endotoxins can produce the same myocardial depression and hemodynamic profile produced by microorganisms with endotoxins (19, 20 (Table II) . Thus, viability was an important virulence factor for both types ofbacteria, but compared to E. coli, the virulence of S. aureus as measured by changes in cardiac function and lethality, was more substantially reduced by formalin-killing. Although the mechanism that enables gram negative bacteria to retain cardiac and general toxicity is unknown, endotoxin, a lipopolysaccharide in the outer membrane of gram negative bacteria, is a preformed toxin resistant to both chemical and physical inactivation. These characteristics of endotoxin may account for the persistent toxicity of formalin-killed E. coli.
The cause of the greater loss of toxicity with this formalinkilled S. aureus compared to this formalin-killed E. coli is unknown. After examining multiple organs (liver, lung, and spleen) immediately postmortem, we found that dogs infected with viable S. aureus as compared to dogs infected with viable E. coli had higher tissue concentrations of bacteria per colony forming unit implanted intraperitoneally. The ability of S. aureus to replicate faster in vivo and to overcome the host defense depends on viability. Thus, loss of S. aureus viability would produce a greater absolute reduction in the number of bacteria that could cause cardiovascular abnormalities and lethality.
The S. aureus used in our experiments did not produce the exotoxin responsible for the toxic shock syndrome (TSST-1). We do not exclude the possibility, however, that some strains of S. aureus may produce specific exotoxins capable of inducing a septic shock syndrome identical to that traditionally associated with gram negative bacilli (30). Recently, Streptococcus pyogenes was reported to cause a shock syndrome with cardiovascular changes similar to those ofgram negative septic shock (31). The occurrence of this streptococcal toxic shock syndrome, which is associated with exotoxin production, suggests that other gram positive organisms may produce a number of toxins capable of inducing a shock syndrome similar to that associated with endotoxin and gram negative sepsis. Such exotoxins would depend on bacterial viability for continued production and release, and thus this mechanism might explain the marked loss of virulence in the formalin-treated S. aureus group.
In this study, the strain of S. aureus used produced higher concentrations of bacteria in postmortem tissue (liver, lung, and spleen) and higher mortality than the E. coli. This S. aureus strain is a common human pathogen and has a virulent capsular serotype. The E. coli strain, (serotype 086;H8) is an uncommon human pathogen and lacks the virulence factors commonly associated with human disease (21) (22) (23) . Therefore, a second virulent E. coli serotype 06;H 1;K2 was also studied. This E. coli serotype is commonly found in human extraintestinal infections and the particular isolate was hemolytic, encapsulated, and serum-resistant, all virulence factors associated with human disease (22, 23). The second E. coli (06;HI;K2), when compared to the S. aureus, was also found to be less virulent (per colony forming unit of viable bacteria implanted intraperitoneally) as judged by postmortem microorganism tissue concentrations and mortality. These results suggest that gram negative microorganisms with endotoxin are not necessarily more toxic than gram positive microorganisms without endotoxin. This finding underscores the importance of a microorganism's ability to produce different toxins and/or mediators that, in turn produce cardiovascular and other abnormalities. We strongly emphasize, however, that the quantitative data presented here regarding virulence per dose of implanted microorganisms pertain to the particular isolates used in this study and might not be generalizable to all gram positive and gram negative bacteria. Furthermore, infectious bacteria commonly invade humans that are immunocompromised or have an anatomic abnormality that predisposes local infection. In this present study, bacterial isolates were implanted into the normal peritoneum of healthy dogs. These host factors may have altered the bacterial kinetics of the infection.
The etiology and pathogenesis of human and animal cardiovascular dysfunction during septic shock are unknown (32) . Studies in humans have demonstrated that reduced coronary blood flow is an unlikely explanation (33). Other recent studies of human septic shock have shown that a circulating myocardial depressant substance was associated qualitatively temporally with the decrease in ejection fraction (34) . This substance may represent the mediator (or one of the mediators) of the myocardial depression produced by viable and nonviable E. coli and/or S. aureus microorganisms.
This present study has demonstrated that the dose, type, and viability of the injected bacteria are all critical factors affecting myocardial depression and mortality. Other factors, such as pattern of injury, time course, and cardiovascular abnormality, however, appear to be independent of bacterial type or viability, suggesting a final common pathway of injury. Furthermore, this study has shown that circulating endotoxin is neither necessary for nor specific to septic shock. These findings suggest that multiple bacterial substances are capable oftriggering a common pathway resulting in similar cardiovascular injury and death.
